Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Advanced Drainage Systems
WMS
$11.4B
| $2.96M | ﹤0.01% |
143,900
+5,700
| +4% | +$119K |
|
|
ALR
2002
DELISTED
Alere Inc
ALR
| $2.96M | ﹤0.01% |
+76,000
| New | +$3.08M |
|
|
PPLI
2003
People Inc
PPLI
$3.01B
| $2.96M | ﹤0.01% |
255,710
-820,438
| -76% | -$9.61M |
|
|
AVH
2004
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $2.96M | ﹤0.01% |
306,900
+145,900
| +91% | +$1.09M |
|
2005
Comtech Telecommunications
CMTL
$52.7M
| $2.96M | ﹤0.01% |
249,500
-239,500
| -49% | -$2.68M |
|
|
GOL
2006
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $2.96M | ﹤0.01% |
1,084,700
-560,500
| -34% | -$2.06M |
|
2007
Agree Realty
ADC
$9.3B
| $2.95M | ﹤0.01% |
64,100
+56,400
| +732% | +$2.57M |
|
2008
Belden
BDC
$5.31B
| $2.95M | ﹤0.01% |
39,400
-106,700
| -73% | -$7.6M |
|
2009
Limoneira
LMNR
$251M
| $2.93M | ﹤0.01% |
136,400
+106,900
| +362% | +$2.07M |
|
|
MYCC
2010
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $2.93M | ﹤0.01% |
204,448
+140,548
| +220% | +$1.87M |
|
2011
SEI Investments
SEIC
$12.8B
| $2.93M | ﹤0.01% |
+59,426
| New | +$2.78M |
|
|
CBB
2012
DELISTED
Cincinnati Bell Inc.
CBB
| $2.93M | ﹤0.01% |
131,040
-142,104
| -52% | -$2.89M |
|
|
TLRA
2013
DELISTED
Telaria, Inc.
TLRA
| $2.92M | ﹤0.01% |
1,173,100
+182,104
| +18% | +$359K |
|
2014
The RMR Group
RMR
$346M
| $2.92M | ﹤0.01% |
73,800
+25,500
| +53% | +$989K |
|
2015
Escalade
ESCA
$276M
| $2.9M | ﹤0.01% |
220,000
+3,800
| +2% | +$49.4K |
|
2016
National Bankshares
NKSH
$270M
| $2.9M | ﹤0.01% |
66,800
+4,100
| +7% | +$155K |
|
2017
Alamo Group
ALG
$2.01B
| $2.9M | ﹤0.01% |
+38,100
| New | +$2.67M |
|
|
EXAC
2018
DELISTED
Exactech Inc
EXAC
| $2.89M | ﹤0.01% |
105,700
+7,100
| +7% | +$188K |
|
|
AC
2019
DELISTED
Associated Capital Group
AC
| $2.88M | ﹤0.01% |
+88,240
| New | +$2.99M |
|
2020
James Hardie Industries
JHX
$18B
| $2.88M | ﹤0.01% |
181,300
+400
| +0.2% | +$6.16K |
|
|
LIOX
2021
DELISTED
Lionbridge Technologies
LIOX
| $2.88M | ﹤0.01% |
496,900
+2,000
| +0.4% | +$10.2K |
|
2022
CMS Energy
CMS
$22.3B
| $2.88M | ﹤0.01% |
69,100
-118,600
| -63% | -$4.85M |
|
2023
Biglari Holdings Class B
BH
$1.21B
| $2.87M | ﹤0.01% |
9,105
+5,670
| +165% | +$1.72M |
|
2024
Lattice Semiconductor
LSCC
$18.5B
| $2.87M | ﹤0.01% |
+389,890
| New | +$2.71M |
|
2025
Altisource Portfolio Solutions
ASPS
$64.4M
| $2.87M | ﹤0.01% |
13,475
+6,250
| +87% | +$1.39M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.